XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Business Segments
 9 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280. Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.

The tables below summarize information about our reportable segments.

 Three Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$236,884 $38,640 $275,524 
Cost of sales110,554 14,568 125,122 
Gross profit126,330 24,072 150,402 
Advertising and marketing24,831 5,592 30,423 
Contribution margin$101,499 $18,480 119,979 
Other operating expenses 32,795 
Operating income $87,184 
* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.

 Nine Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$731,456 $110,400 $841,856 
Cost of sales327,008 43,318 370,326 
Gross profit404,448 67,082 471,530 
Advertising and marketing99,559 14,634 114,193 
Contribution margin$304,889 $52,448 357,337 
Other operating expenses 98,755 
Operating income $258,582 
* Intersegment revenues of $2.8 million were eliminated from the North American OTC Healthcare segment.


 Three Months Ended December 31, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$240,857 $33,613 $274,470 
Cost of sales106,790 12,620 119,410 
Gross profit 134,067 20,993 155,060 
Advertising and marketing34,907 5,332 40,239 
Contribution margin$99,160 $15,661 114,821 
Other operating expenses 32,227 
Operating income $82,594 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.
 Nine Months Ended December 31, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$734,978 $84,898 $819,876 
Cost of sales314,817 33,275 348,092 
Gross profit 420,161 51,623 471,784 
Advertising and marketing106,630 13,778 120,408 
Contribution margin$313,531 $37,845 351,376 
Other operating expenses 98,882 
Operating income $252,494 
* Intersegment revenues of $2.4 million were eliminated from the North American OTC Healthcare segment.


The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$29,396 $648 $30,044 
Cough & Cold31,246 6,336 37,582 
Women's Health53,918 4,138 58,056 
Gastrointestinal38,194 18,555 56,749 
Eye & Ear Care32,653 5,229 37,882 
Dermatologicals27,223 978 28,201 
Oral Care21,371 2,738 24,109 
Other OTC2,883 18 2,901 
Total segment revenues$236,884 $38,640 $275,524 

Nine Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$89,943 $1,642 $91,585 
Cough & Cold76,896 19,775 96,671 
Women's Health174,481 13,750 188,231 
Gastrointestinal119,533 48,619 168,152 
Eye & Ear Care109,225 14,699 123,924 
Dermatologicals89,550 2,886 92,436 
Oral Care63,597 8,988 72,585 
Other OTC8,231 41 8,272 
Total segment revenues$731,456 $110,400 $841,856 
Three Months Ended December 31, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$30,805 $225 $31,030 
Cough & Cold25,861 5,864 31,725 
Women's Health61,826 3,741 65,567 
Gastrointestinal34,830 16,423 51,253 
Eye & Ear Care35,996 3,572 39,568 
Dermatologicals26,589 777 27,366 
Oral Care22,202 3,007 25,209 
Other OTC2,748 4 2,752 
Total segment revenues$240,857 $33,613 $274,470 
Nine Months Ended December 31, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$93,569 $1,027 $94,596 
Cough & Cold62,928 15,717 78,645 
Women's Health190,094 11,030 201,124 
Gastrointestinal115,160 35,268 150,428 
Eye & Ear Care109,801 10,018 119,819 
Dermatologicals90,104 2,555 92,659 
Oral Care66,062 9,274 75,336 
Other OTC7,260 9 7,269 
Total segment revenues$734,978 $84,898 $819,876